Alterity Therapeutics Announces Presentation of bioMUSE Data at the American Academy of Neurology (AAN) Annual Meeting April 7, 2022August 16, 2022
Alterity announces funding from Michael J. Fox Foundation for ATH434 dose optimization for Parkinson’s disease clinical trials February 9, 2021August 16, 2022
Alterity Therapeutics to Participate in Two Upcoming Investor Conferences November 22, 2021August 16, 2022
